Nuclear Cardiology

Single photon computed tomography (SPECT) and positron emission tomography (PET) molecular imaging are used as primary cardiac imaging modalities to evaluate the function of the heart. It uses radioactive isotopes attached to sugars that are metabolized by cardiomyocytes. This creates an image of the metabolic activity of the heart and shows areas of ischemia or infarct. Other radiotracers can image the heart to diagnosis cardiac amyloidosis and sarcoidosis. 

Thumbnail

American Society of Nuclear Cardiology says AHA/ACC chest pain guidelines miss the mark

One of the group's primary concerns is the "inappropriately large role" given to FFR-CT. 

Thumbnail

‘A troublesome trend’: Top imaging groups slam insurer-directed test substitution policies

Advocates say payers' push for single first-line imaging tests for all patients isn't backed by evidence and may cause harm.

Medical isotope specialist NorthStar announces new executive hire

Frank Scholz, PhD, will oversee the Beloit, Wisconsin, firm's Mo-99 expansion efforts and new radioisotope development programs, among other duties.

Thumbnail

Combining AI with cardiac imaging helps predict heart attacks, cardiovascular deaths

The findings were presented virtually during the Society of Nuclear Medicine and Molecular Imaging's 2021 Annual Meeting.

Thumbnail

Imaging advocates offer guidance after reported spate of SPECT/CT payment denials

The Society of Nuclear Medicine & Molecular Imaging said it’s received “many complaints” from the field pertaining to various commercial payers. 

M&A mergers and acquisitions business deal

Medical imaging isotope producer Shine finalizes merger with fusion technology specialist

With the help of Phoenix's advanced industrial imaging capabilities, the new entity hopes to ramp up its production of molybdenum-99.

chest pain lung pulmonary embolism

CCTA is a safe, effective alternative to SPECT in patients with stable chest pain

The findings come by way of the RESCUE Trial, which included more than 1,000 participants from 44 different sites.

Humana

Imaging experts slam Humana for ‘ill-informed and wrong’ decision to deny coverage for PET/CT exams

The pair said that without hearing a solid argument, they will be "relentless" in opposing the insurance giant's coverage determination. 

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.